Federation des caisses Desjardins du Quebec’s Amneal Pharmaceuticals AMRX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-100	Closed	-$809	–	2884
2025 Q2	$809	Hold	100	–	–	﹤0.01%	2530
2025 Q1	$838	Hold	100	–	–	﹤0.01%	2437
2024 Q4	$792	Hold	100	–	–	﹤0.01%	2344
2024 Q3	$832	Buy	+100	New	+$782	﹤0.01%	2339
2019 Q2	–	Sell	-10,830	Closed	-$153K	–	2261
2019 Q1	$153K	Sell	10,830 -4,460	-29%	-$58.9K	﹤0.01%	1049
2018 Q4	$207K	Hold	15,290	–	–	﹤0.01%	970
2018 Q3	$339K	Sell	15,290 -658	-4%	-$13.8K	0.01%	849
2018 Q2	$262K	Buy	+15,948	New	+$280K	﹤0.01%	983

Other funds holding AMRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's AMRX Position: Q3 2025 in Review

Federation des caisses Desjardins du Quebec sold out of Amneal Pharmaceuticals (AMRX) in Q3 2025, closing a stake of 100 shares — an estimated $809 sold.

Federation des caisses Desjardins du Quebec first reported a position in AMRX in Q2 2018 and held it in 8 quarters. The position peaked at $339K in Q3 2018. 248 funds tracked by Wall St. Rank hold AMRX as of Q3 2025.

Federation des caisses Desjardins du Quebec reported no remaining Amneal Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 100 Amneal Pharmaceuticals shares in Q3 2025, an estimated $809.
Federation des caisses Desjardins du Quebec first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 8 quarters.
Federation des caisses Desjardins du Quebec's Amneal Pharmaceuticals position peaked at $339K in Q3 2018.
248 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2025, filed 14 Nov 2025.